Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ghio

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
European Journal of Internal Medicine|May 18, 2026
Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registryR Madonna, A M Marra, F Biondi, et al.
Cardio-Oncology (London, England)|September 2, 2025
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trialA Greco, V Quagliariello, G Rizzo, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
European Journal of Internal Medicine|May 18, 2026
Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registryR Madonna, A M Marra, F Biondi, et al.
Cardio-Oncology (London, England)|September 2, 2025
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trialA Greco, V Quagliariello, G Rizzo, et al.
Pageof 7